News

Shares of software development tools maker GitLab (NASDAQ:GTLB) fell 9.5% in the afternoon session after the company reported ...
The takeaway is that GTLB is a screaming buy with its shares trading near the bottom of a two-year range, price points ...
Software development tools maker GitLab (NASDAQ:GTLB) announced in Q1 CY2025, with sales up 26.8% year on year to $214.5 ...
GitLab's strong fundamentals and intact growth story make its current share price an attractive opportunity despite market ...
GitLab (NASDAQ:GTLB – Free Report) had its target price boosted by Morgan Stanley from $53.00 to $56.00 in a research report sent to investors on Wednesday,Benzinga reports. The firm currently has an ...
GitLab (NASDAQ:GTLB – Free Report) had its price target lowered by UBS Group from $85.00 to $73.00 in a report issued on Wednesday,Benzinga reports. UBS Group currently has a buy rating on the stock.
Software stock GitLab (GTLB) is suffering steep losses after the company's disappointing quarterly and full-year outlook ...
GitLab (GTLB) shares dropped 10% during early Wednesday trading, after its first quarter fiscal 2026 results produced its ...
Although the revenue and EPS for Gitlab (GTLB) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street ...
The BEAM Trade: Ark Invest’s ARK Innovation ETF ARKK +0.83% + Free Alerts purchased 349,264 shares of Beam Therapeutics. The ...
Outlook: Gitlab sees second-quarter adjusted earnings per share from 16 cents to 17 cents, versus the consensus estimate of ...
However, GitLab’s Q2 revenue guidance of $226-227 million fell short of Wall Street’s $227 million projection, overshadowing ...